When superbug infections spread across hospitals, scientists are often left puzzled at how the pathogens spread. A new paper suggests its down to genetics.
The FDA has warned that it will be coming down hard on anyone carrying out do-it-yourself gene therapy, in a recent statement.
GlaxoSmith Kline (GSK) has welcomed the news that two of its drug regimen to treat HIV have won US approval, with its Juluca treatment.
Pfizer has found itself in a battle with several states who are intending to use some of its drugs to carry out executions.
One under the radar biotech could be trumping all its competitors, after it makes significant progress in potentially producing an Alzheimer’s treatment.
This Thanksgiving investors are thankful that the S&P 500 is up about 15% year to date, with that path expected to continue to the end of the year.
A genome-wide association study has identified 4 novel SNPs that may be able to act as prognostic tools for early-onset breast cancer in young women
The three big players in the world of cloud computing released their quarterly earnings this week, and it’s clear who’s speeding ahead.
A team of scientists have developed new nano-mapping technology that could transform the way disease-causing genetic mutations are diagnosed and discovered.
The FDA has released new guidelines in a bid to quicken the implementation of treatments involving human cells and tissues, including gene therapy.
We’ve caught up with Luca Magnani ahead of his talk: ‘Diving into the Dark Matter of the Cancer Genome’ at the Festival of Genomics.
It has been revealed that China now ranks third, trailing the likes of the US and the UK, in the list of most highly cited authors worldwide.